Growth Factors of Diabetes Treatment Devices Market
The global diabetes treatment devices market size was valued at USD 10.83 billion in 2018 and is projected tgrow tUSD 22.83 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period of 2019-2032.
The COVID-19 pandemic disrupted shipping chains and healthcare entry, affecting the Diabetes Treatment Devices Market. However, it expanded the call for domestic-use devices like insulin pumps and non-stop glucose videshow gadgets, driven by the desire for extended growthway-flung healthcare and self-control tools, impeding the diabetes treatment devices market.
The Diabetes Treatment Devices Market is pushed via the rising occurrence of diabetes, technological advancements in insulin shipping systems, the growing adoption of wearable gadgets for diabetes control, and growing interest in self-management systems. Supportive authorities' projects and transfers towards domestic healthcare have alscontributed tthe market boom.
The Diabetes Treatment Devices Market is experiencing an enormous boom, driven by the rising occurrence of diabetes globally and the growing demand for stepped-forward glycemic control. Key traits encompass developing sophisticated non-prevent glucose tracking (CGM) structures with extra accuracy and capabilities like actual-time indicators, predictive analytics, and expanding diabetes treatment devices market share globally. Additionally, improvements in insulin shipping systems, computerized insulin delivery systems (AID), and wearable insulin pumps allow greater customized and powerful diabetes management.
Comprehensive Analysis of Diabetes Treatment Devices Market
The Diabetes Treatment Devices Market is segmented intmerchandise and distribution channels. By product, the market includes insulin pens, insulin pumps, insulin jet injectors, insulin syringes, and others. The insulin pens segment is predicted texpand swiftly because of their comfort and minimum invasiveness compared tconventional insulin syringes. Insulin pumps, which constantly infuse insulin, are alsexpected tenjoy a giant growth due tthe more and more widespread type one diabetes patients. The distribution channel cuts the marketplace intretail and institutional earnings. Retail sales are anticipated tdominate because of the growing availability of personal-label producers and partnerships between marketplace players tincrease earnings globally. Meanwhile, institutional income is pushed through the call for blood glucose monitors in hospitals, mainly for non-diabetic sufferers.
The Asia Pacific region led the diabetes treatment devices market by benefitting a size of USD 4.38 billion in 2018 due tthe adoption of technologically advanced insulin shipping devices and the elevated call for for minimally invasive insulin delivery gadgets.
The leading players in the diabetes treatment devices market significantly influence its growth trajectory and set industry standards. These key players, including F. Hoffmann-La Roche Ltd (Switzerland), Tandem Diabetes Care, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic (Ireland), BD (U.S.), NovNordisk A/S (Denmark), Abbott (U.S.), and Sanofi (France), contribute ta competitive landscape, driving innovation and advancements in diabetes care technologies. These companies continue tshape the market with cutting-edge solutions, expanding access tadvanced insulin delivery devices and other treatment solutions.
In April 2021, BIOCORP and Roche Diabetes Care, France, revealed the advent of Mallya, a clever insulin injection pen. This partnership will enable BIOCORP tutilize Roche's substantial distribution network in pharmacies.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2015-2026
Base Year 2018
Forecast Period 2019-2026
Historical Period 2015-2017
Unit Value (USD billion)
Segmentation By Product
Insulin Pens
Insulin Pumps
Insulin Jet Injectors
Insulin Syringes
Others
By Distribution Channel
Institutional Sales
Hospitals
Clinics
Others
Retail Sales
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence and Incidence of Diabetes by Key Countries
- 4.2. Advancements in Insulin Delivery Devices
- 4.3. Pricing Analysis, By Key Countries/ Key Regions
- 4.4. Recent Industry Developments Such As Mergers & Acquisitions
- 5. Global Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Insulin Pens
- 5.2.2. Insulin Pumps
- 5.2.3. Insulin Jet Injectors
- 5.2.4. Insulin Syringes
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.3.1. Institutional Sales
- 5.3.1.1. Hospitals
- 5.3.1.2. Clinics
- 5.3.1.3. Others
- 5.3.2. Retail Sales
- 5.3.2.1. Online Pharmacies
- 5.3.2.2. Hospital Pharmacies
- 5.3.2.3. Retail Pharmacies
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Insulin Pens
- 6.2.2. Insulin Pumps
- 6.2.3. Insulin Jet Injectors
- 6.2.4. Insulin Syringes
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.3.1. Institutional Sales
- 6.3.1.1. Hospitals
- 6.3.1.2. Clinics
- 6.3.1.3. Others
- 6.3.2. Retail Sales
- 6.3.2.1. Online Pharmacies
- 6.3.2.2. Hospital Pharmacies
- 6.3.2.3. Retail Pharmacies
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Insulin Pens
- 7.2.2. Insulin Pumps
- 7.2.3. Insulin Jet Injectors
- 7.2.4. Insulin Syringes
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.3.1. Institutional Sales
- 7.3.1.1. Hospitals
- 7.3.1.2. Clinics
- 7.3.1.3. Others
- 7.3.2. Retail Sales
- 7.3.2.1. Online Pharmacies
- 7.3.2.2. Hospital Pharmacies
- 7.3.2.3. Retail Pharmacies
- 7.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
- 7.4.1. U.K.
- 7.4.2. Spain
- 7.4.3. Italy
- 7.4.4. Germany
- 7.4.5. France
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Insulin Pens
- 8.2.2. Insulin Pumps
- 8.2.3. Insulin Jet Injectors
- 8.2.4. Insulin Syringes
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.3.1. Institutional Sales
- 8.3.1.1. Hospitals
- 8.3.1.2. Clinics
- 8.3.1.3. Others
- 8.3.2. Retail Sales
- 8.3.2.1. Online Pharmacies
- 8.3.2.2. Hospital Pharmacies
- 8.3.2.3. Retail Pharmacies
- 8.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Australia
- 8.4.4. Japan
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Insulin Pens
- 9.2.2. Insulin Pumps
- 9.2.3. Insulin Jet Injectors
- 9.2.4. Insulin Syringes
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.3.1. Institutional Sales
- 9.3.1.1. Hospitals
- 9.3.1.2. Clinics
- 9.3.1.3. Others
- 9.3.2. Retail Sales
- 9.3.2.1. Online Pharmacies
- 9.3.2.2. Hospital Pharmacies
- 9.3.2.3. Retail Pharmacies
- 9.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product
- 10.2.1. Insulin Pens
- 10.2.2. Insulin Pumps
- 10.2.3. Insulin Jet Injectors
- 10.2.4. Insulin Syringes
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.3.1. Institutional Sales
- 10.3.1.1. Hospitals
- 10.3.1.2. Clinics
- 10.3.1.3. Others
- 10.3.2. Retail Sales
- 10.3.2.1. Online Pharmacies
- 10.3.2.2. Hospital Pharmacies
- 10.3.2.3. Retail Pharmacies
- 10.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
- 10.4.1. South Africa
- 10.4.2. GCC
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles
- 11.5.1. F. Hoffmann-La Roche Ltd
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. Tandem Diabetes Care, Inc.
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. B. Braun Melsungen AG
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. PHC Holdings Corporation
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. Medtronic
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. BD
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. Novo Nordisk A/S
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Abbott
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. Other Prominent Players
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 12. Strategic Recommendations "
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook